Financials
- Market Capitalization 432.22 M
- Employee 48
- Founded 2020
- CEO N/A
- Website www.evommune.com
- Headquarter Delaware, United States
- FIGI BBG00Y79N887
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.53
ratio cours/chiffre d'affaires
8.08
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2993 | SLN Silence Therapeutics Plc - American Depository Share | 9.79 USD | +5.38% | -3.55% | +44.18% | +54.91% | 462.43 M USD | ||
| 3000 | VALN Valneva SE - American Depositary Shares | 5.14 USD | -2.28% | -2.28% | -6.03% | -21.29% | 446.00 M USD | ||
| 3011 | STRO Sutro Biopharma, Inc. - Common Stock | 25.99 USD | -6.65% | -19.11% | -9.76% | +49.45% | 430.67 M USD | ||
| 3013 | CABA Cabaletta Bio, Inc. - Common Stock | 2.66 USD | -3.97% | -14.19% | -13.92% | +56.47% | 433.73 M USD |